|
|
|
|
|
COVID-19's Impact: Help Ensure Quality and Manage Risk
|
|
|
|
|
The COVID-19 pandemic has disrupted the drug manufacturing industry unlike any the global supply chain has seen—from the FDA's process for inspecting drug manufacturing facilities to ingredient and product shortages with subsequent surges. USP’s Danita Broyles discusses these challenges and USP’s solutions to help ensure quality and manage risks across the global supply chain.
|
|
|
|
|
Differentiate your ingredients in an increasingly competitive global market.
The USP Ingredient Verification Program helps you ensure the quality of APIs and excipients in addition to differentiating yourself as dedicated to quality.
|
|
|
|
|
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.
|
|
|
|
